still hungry on glp 1 feeling a GLP-1? Here are a few reasons why that might be happening 💡 Still hungry on GLP-1? This

The standard therapeutic dose is 1.2 mg once daily, which can be increased to 1.8 mg to further enhance glycemic control

Recent studies suggest that glucagon receptor signaling is disrupted in NAFLD, indicating that supra-physiological glucagon receptor agonism might represent a new NAFLD treatment target

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Park J.S., Kam T.I., Lee S., Park H., Oh Y., Kwon S.H., et al

Retatrutide, a triple hormone agonist targeting GIP, GLP-1, and glucagon receptors, has shown promising early results that may exceed Mounjaro in some measures

For someone seeking a convenient, GLP-1-friendly option, Laird's Protein Instant Latte may help provide the protein and real food ingredients needed to support satiety and balanced energy